Will the stock go upto $90 now so I can sell and get out of this pathetic stock?
7 replies (most recent on top)
Imagine where the stock would go if it didn’t get approval. Earnings call would have been tough.
Not a big bump in the stock price on the approval news (+0.42 or +0.53% as of now). I was thinking/hoping it would be a lot higher than that unless Wall Street thinks the lack of reimbursement is going to be a major issue. That or maybe factoring in earnings that will be released tomorrow?
Chance of reimbursement is zero. This is DOA and the data is unconvincing at best, bullsh*t at worst. This kind of garbage getting approved is kind of why the US health care system is where it is. Forget medical management...his therapy failed against sham procedures. Medication still works, that's basically what the On Med data showed aka, this is a useless therapy not to mention a heavy burden on the healthcare system because MDT is going to milk every penny out of this to pay for the 2B it's already flushed into it. Completely failure of an approval.
Will Medtronic's renal denervation have reimbursement right away or do they have to go through the process of getting commercial payors and Medicare/Medicaid on board? It's nice to get FDA approval, but without solid data, will insurers even pay for this procedure?
The product has failed on multiple occasions to meet primary end points of performance. The product failed to show superiority over sham procedures.
US FDA is achieved with a a very suboptimal claim. The reimbursement authorities will find it difficult to pay for the procedure.
Some naive investors will jump to this news but the heavyweights would keep away. Don’t expect more than $5 increase at the most optimistic level.
What a wet fa-t of a product.
If that announcement pushes it up $2 I would consider it a win.